Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis: American …
S MacLean, S Mulla, EA Akl, M Jankowski, PO Vandvik… - Chest, 2012 - Elsevier
Background Development of clinical practice guidelines involves making trade-offs between
desirable and undesirable consequences of alternative management strategies. Although …
desirable and undesirable consequences of alternative management strategies. Although …
Treatment of cancer-associated thrombosis
AYY Lee, EA Peterson - Blood, The Journal of the American …, 2013 - ashpublications.org
Therapeutic options for the management of venous thromboembolism (VTE) in patients with
cancer remain very limited. Although low-molecular-weight heparin monotherapy has been …
cancer remain very limited. Although low-molecular-weight heparin monotherapy has been …
Anticoagulation of cancer patients with non‐valvular atrial fibrillation receiving chemotherapy: guidance from the SSC of the ISTH
1 BACKGROUND Atrial fibrillation is the most common cardiac arrhythmia, affecting
approximately 1.5% to 2% of the general population, increasing by a further 1.8% in the …
approximately 1.5% to 2% of the general population, increasing by a further 1.8% in the …
Does IQ explain socioeconomic inequalities in health? Evidence from a population based cohort study in the west of Scotland
Objective To test the hypothesis that IQ is a fundamental cause of socioeconomic
inequalities in health. Design Cross sectional and prospective cohort study, in which …
inequalities in health. Design Cross sectional and prospective cohort study, in which …
Patients' Experiences of LIving with CANcer-associated thrombosis: the PELICAN study
Introduction Thrombosis remains the most common preventable cause of mortality in cancer
patients receiving chemotherapy. Whilst the prophylaxis and treatment of this condition is …
patients receiving chemotherapy. Whilst the prophylaxis and treatment of this condition is …
[HTML][HTML] Assessing patients' anticoagulation preferences for the treatment of cancer-associated thrombosis using conjoint methodology
S Noble, A Matzdorff, A Maraveyas, MV Holm… - …, 2015 - ncbi.nlm.nih.gov
Low molecular weight heparins have demonstrated superiority over coumarins in the
extended treatment of cancer-associated thrombosis and are recommended as first-line …
extended treatment of cancer-associated thrombosis and are recommended as first-line …
[HTML][HTML] Factors influencing adherence to clinical guidelines in the management of cancer‐associated thrombosis
I Mahé, J Chidiac, H Helfer, S Noble - Journal of Thrombosis and …, 2016 - Elsevier
International academic and regulatory guidelines consistently recommend the long‐term
use of low‐molecular‐weight heparins (LMWHs) as the standard for the treatment of cancer …
use of low‐molecular‐weight heparins (LMWHs) as the standard for the treatment of cancer …
Cancer and stroke: what do we know and where do we go?
Cancer is an increasingly recognized cause for ischemic stroke, with recent
acknowledgement of cancer-related stroke as an emerging stroke subtype with unique …
acknowledgement of cancer-related stroke as an emerging stroke subtype with unique …
Cancer-associated thrombosis, low-molecular-weight heparin, and the patient experience: a qualitative study
Background Venous thromboembolism is a common complication of cancer and its
treatments. Treatment of cancer-associated thrombosis (CAT) differs from treatment of …
treatments. Treatment of cancer-associated thrombosis (CAT) differs from treatment of …
Long-term psychological consequences of symptomatic pulmonary embolism: a qualitative study
S Noble, R Lewis, J Whithers, S Lewis, P Bennett - BMJ open, 2014 - bmjopen.bmj.com
Objective To explore the psychological consequences of experiencing symptomatic
pulmonary embolism (PE). Design Qualitative interview-based study using interpretative …
pulmonary embolism (PE). Design Qualitative interview-based study using interpretative …